Your browser doesn't support javascript.
loading
The epidemiology of drug use disorders cross-nationally: Findings from the WHO's World Mental Health Surveys.
Degenhardt, Louisa; Bharat, Chrianna; Glantz, Meyer D; Sampson, Nancy A; Scott, Kate; Lim, Carmen C W; Aguilar-Gaxiola, Sergio; Al-Hamzawi, Ali; Alonso, Jordi; Andrade, Laura H; Bromet, Evelyn J; Bruffaerts, Ronny; Bunting, Brendan; de Girolamo, Giovanni; Gureje, Oye; Haro, Josep Maria; Harris, Meredith G; He, Yanling; de Jonge, Peter; Karam, Elie G; Karam, Georges E; Kiejna, Andrzej; Lee, Sing; Lepine, Jean-Pierre; Levinson, Daphna; Makanjuola, Victor; Medina-Mora, Maria Elena; Mneimneh, Zeina; Navarro-Mateu, Fernando; Posada-Villa, José; Stein, Dan J; Tachimori, Hisateru; Torres, Yolanda; Zarkov, Zahari; Chatterji, Somnath; Kessler, Ronald C.
Afiliação
  • Degenhardt L; National Drug and Alcohol Research Centre (NDARC), UNSW Sydney, Sydney, Australia. Electronic address: l.degenhardt@unsw.edu.au.
  • Bharat C; National Drug and Alcohol Research Centre (NDARC), UNSW Sydney, Sydney, Australia.
  • Glantz MD; Department of Epidemiology, Services, and Prevention Research (DESPR), National Institute on Drug Abuse (NIDA), National Institute of Health (NIH), Bethesda, MD, USA.
  • Sampson NA; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
  • Scott K; Department of Psychological Medicine, University of Otago, Dunedin, Otago, New Zealand.
  • Lim CCW; Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Queensland, Australia; Queensland Brain Institute, University of Queensland, St Lucia, Queensland, Australia.
  • Aguilar-Gaxiola S; Center for Reducing Health Disparities, UC Davis Health System, Sacramento, CA, USA.
  • Al-Hamzawi A; College of Medicine, Al-Qadisiya University, Diwaniya governorate, Iraq.
  • Alonso J; Health Services Research Unit, IMIM-Hospital del Mar Medical Research Institute, Barcelona, Spain; Pompeu Fabra University (UPF), Barcelona, Spain; CIBER en Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Andrade LH; Núcleo de Epidemiologia Psiquiátrica - LIM 23, Instituto de Psiquiatria Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, Brazil.
  • Bromet EJ; Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA.
  • Bruffaerts R; Universitair Psychiatrisch Centrum - Katholieke Universiteit Leuven (UPC-KUL), Campus Gasthuisberg, Leuven, Belgium.
  • Bunting B; School of Psychology, Ulster University, Londonderry, United Kingdom.
  • de Girolamo G; IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, Brescia, Italy.
  • Gureje O; Department of Psychiatry, University College Hospital, Ibadan, Nigeria.
  • Haro JM; Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Barcelona, Sant Boi de Llobregat, Barcelona, Spain.
  • Harris MG; Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Queensland, Australia; School of Public Health, The University of Queensland, QLD, Australia.
  • He Y; Shanghai Mental Health Center, Shanghai Jiao Tong University, School of Medicine, Shanghai, China.
  • de Jonge P; Developmental Psychology, Department of Psychology, Rijksuniversiteit Groningen, Groningen, The Netherlands; Interdisciplinary Center Psychopathology and Emotion Regulation, Department of Psychiatry, University Medical Center Groningen, Groningen, The Netherlands.
  • Karam EG; Department of Psychiatry and Clinical Psychology, Faculty of Medicine, Balamand University, Beirut, Lebanon; Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Beirut, Lebanon; Institute for Development Research Advocacy and Applied Care (IDRAAC), Beirut,
  • Karam GE; Institute for Development Research Advocacy and Applied Care (IDRAAC), Beirut, Lebanon; Department of Psychiatry and Clinical Psychology, St George Hospital University Medical Center, Balamand University, Faculty of Medicine, Beirut, Lebanon.
  • Kiejna A; Wroclaw Medical University, Wroclaw, Poland; University of Lower Silesia, Wroclaw, Poland.
  • Lee S; Department of Psychiatry, Chinese University of Hong Kong, Tai Po, Hong Kong.
  • Lepine JP; Hôpital Lariboisière- Fernand Widal, Assistance Publique Hôpitaux de Paris, Paris, France; Universités Paris Descartes-Paris Diderot, Paris, France; Institut National de la Sante et de la Recherche Medicale (INSERM) UMR-S 1144, Paris, France.
  • Levinson D; Mental Health Services, Ministry of Health, Jerusalem, Israel.
  • Makanjuola V; Department of Psychiatry, College of Medicine, University of Ibadan, Ibadan, Nigeria; University College Hospital, Ibadan, Nigeria.
  • Medina-Mora ME; National Institute of Psychiatry Ramón de la Fuente Muñiz, Mexico City, Mexico.
  • Mneimneh Z; Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.
  • Navarro-Mateu F; Unidad de Docencia, Investigación y Formación en Salud Mental (UDIF-SM), Servicio Murciano de Salud, Murcia, Spain; IMIB-Arrixaca, Murcia, Spain; CIBER de Epidemiología y Salud Pública (CIBERESP), Murcia, Spain.
  • Posada-Villa J; Colegio Mayor de Cundinamarca University, Faculty of Social Sciences, Bogota, Colombia.
  • Stein DJ; Department of Psychiatry & Mental Health and South African Medical Council Research Unit on Risk and Resilience in Mental Disorders, University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa.
  • Tachimori H; National Institute of Mental Health, National Center for Neurology and Psychiatry, Kodaira, Tokyo, Japan.
  • Torres Y; Center for Excellence on Research in Mental Health, CES University, Medellin, Colombia.
  • Zarkov Z; Directorate Mental Health, National Center of Public Health and Analyses, Sofia, Bulgaria.
  • Chatterji S; Department of Information, Evidence and Research, World Health Organization, Geneva, Switzerland.
  • Kessler RC; Department of Health Care Policy, Harvard Medical School, Boston, MA, USA.
Int J Drug Policy ; 71: 103-112, 2019 09.
Article em En | MEDLINE | ID: mdl-31255918
BACKGROUND: Illicit drug use and associated disease burden are estimated to have increased over the past few decades, but large gaps remain in our knowledge of the extent of use of these drugs, and especially the extent of problem or dependent use, hampering confident cross-national comparisons. The World Mental Health (WMH) Surveys Initiative involves a standardised method for assessing mental and substance use disorders via structured diagnostic interviews in representative community samples of adults. We conducted cross-national comparisons of the prevalence and correlates of drug use disorders (DUDs) in countries of varied economic, social and cultural nature. METHODS AND FINDINGS: DSM-IV DUDs were assessed in 27 WMH surveys in 25 countries. Across surveys, the prevalence of lifetime DUD was 3.5%, 0.7% in the past year. Lifetime DUD prevalence increased with country income: 0.9% in low/lower-middle income countries, 2.5% in upper-middle income countries, 4.8% in high-income countries. Significant differences in 12-month prevalence of DUDs were found across country in income groups in the entire cohort, but not when limited to users. DUDs were more common among men than women and younger than older respondents. Among those with a DUD and at least one other mental disorder, onset of the DUD was usually preceded by the 'other' mental disorder. CONCLUSIONS: Substantial cross-national differences in DUD prevalence were found, reflecting myriad social, environmental, legal and other influences. Nonetheless, patterns of course and correlates of DUDs were strikingly consistent. These findings provide foundational data on country-level comparisons of DUDs.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comparação Transcultural / Transtornos Relacionados ao Uso de Substâncias / Transtornos Mentais Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Comparação Transcultural / Transtornos Relacionados ao Uso de Substâncias / Transtornos Mentais Idioma: En Ano de publicação: 2019 Tipo de documento: Article